FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
Becker's Hospital Review10h
FDA mandates warnings for 2 RSV vaccines
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
World’s largest proteins study ‘invaluable’ for understanding disease – experts
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
New blood test reveals risk of developing different diseases in 'new frontier of science'
A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...
Royalty Pharma Announces Dividend Increase
NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ...
Pharma companies welcome new year with 583 drug price hikes so far
Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...
Drugs not selected for Medicare price negotiation nearly doubled - report
The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...
Managed Healthcare Executive5h
FDA Requires Guillain-Barré Warning for Abrysvo and Arexvy
Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...